Problems With Drugs That Get Speedy OKs: What To Do? Problems With Drugs That Get Speedy OKs: What To Do?
Many drugs with accelerated approvals lack ' high added ' value compared with other therapies, and conducting further trials of these drugs is financially risky for the manufacturers.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Hematology